关于动脉样硬化分子机制的新见解
Armanda Wojtasińska1, Weronika Frąk1, Wiktoria Lisińska1
1Department of Nephrocardiology, Medical University of Lodz, ul. Zeromskiego 113, 90-549 Lodz, Poland.
International journal of molecular sciences
|September 9, 2023
概括
动脉样硬化是一种致命的动脉疾病,涉及诸如内皮功能障碍和炎症等复杂的机制. 了解分子相互作用,包括尿酸和维生素D,有助于预防心血管疾病.
科学领域:
- 心血管研究研究心血管研究
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 动脉样硬化是全球死亡的主要原因.
- 这是一种复杂的疾病,涉及动脉壁加厚和多种促成因素.
- 研究涵盖了分子生物学,心脏学和免疫学.
研究的目的:
- 审查动脉样硬化的病理生理机制.
- 突出最近关于分子和细胞相互作用的证据.
- 帮助理解和预防心血管疾病.
主要方法:
- 关于病理生理学影响的文献综述.
- 专注于内皮功能障碍和炎症.
- 包括关于衰老,尿酸,维生素D和miRNA的最新发现.
主要成果:
- 动脉样硬化涉及分子和细胞元素之间的复杂相互作用.
- 内皮功能障碍和炎症是关键因素.
- 尿酸,维生素D和miRNA的表达都在其中.
结论:
- 新的发现提高了对动脉样硬化病理生理学的理解.
- 在心血管疾病预防中改善理解辅助.
- 跨学科的研究对于推进知识至关重要.
相关概念视频
Atherosclerosis I: Introduction
9
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
9
Coronary Artery Disease II: Pathophysiology
12
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
12
Atherosclerosis III: Management
12
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12
Coronary Artery Disease I: Introduction
20
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
20
Inflammation
53.8K
Overview
53.8K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
13
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
13


